Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK Biobank. | Br J Cancer | 2024 | 39294438 | PubTator, text mining | PubMed |
| Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort. | Cancers (Basel) | 2024 | 39272924 | PubTator, text mining | PubMed |
| Economic evaluation of extended panel analysis in cancer patients with historical NHS diagnostic germline genetic testing - A modeling study based on real-world data. | Eur J Med Genet | 2024 | 39260602 | PubTator, text mining | PubMed |
| Prevalence of germline variants in Brazilian pancreatic carcinoma patients. | Sci Rep | 2024 | 39256447 | PubTator, text mining | PubMed |
| Molecular Analysis of Renal/Adrenal Angiosarcomas Reveals High Frequency of Recurrent Genetic Alterations. | Genes Chromosomes Cancer | 2024 | 39248552 | PubTator, text mining | PubMed |
| Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. | JAMA Netw Open | 2024 | 39226054 | PubTator, text mining | PubMed |
| DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. | JCO Precis Oncol | 2024 | 39178368 | PubTator, text mining | PubMed |
| A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. | Cancer Med | 2024 | 39149814 | PubTator, text mining | PubMed |
| Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. | Gastric Cancer | 2024 | 39110344 | PubTator, text mining | PubMed |
| Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene. | Genet Med | 2024 | 39096152 | PubTator, text mining | PubMed |
| Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status. | Breast Cancer Res Treat | 2024 | 39080120 | PubTator, text mining | PubMed |
| Systematic investigation of BRCA1-A, -B, and -C complexes and their functions in DNA damage response and DNA repair. | Oncogene | 2024 | 39068216 | PubTator, text mining | PubMed |
| Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. | Cancers (Basel) | 2024 | 39061189 | PubTator, text mining | PubMed |
| Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants. | Cancers (Basel) | 2024 | 39001544 | PubTator, text mining | PubMed |
| Lung Adenocarcinoma Systems Biomarker and Drug Candidates Identified by Machine Learning, Gene Expression Data, and Integrative Bioinformatics Pipeline. | OMICS | 2024 | 38979602 | PubTator, text mining | PubMed |
| Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients. | PLoS One | 2024 | 38976671 | PubTator, text mining | PubMed |
| Germline Co-deletion of CDKN2A and CDKN2B Genes in Pleomorphic Xanthoastrocytoma: Case Report. | In Vivo | 2024 | 38936911 | PubTator, text mining | PubMed |
| A Systematic Review of the Prevalence of Germline BRCA mutations in North Asia Breast Cancer Patients. | Asian Pac J Cancer Prev | 2024 | 38918649 | PubTator, text mining | PubMed |
| Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations. | Ochsner J | 2024 | 38912178 | PubTator, text mining | PubMed |
| Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer. | J Natl Compr Canc Netw | 2024 | 38866043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=11